fuganlin
Small moleculeexperimental
Clinical trial activity
1 trials · 9 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Mar 1, 2012 (NCT02622659)
Timeline
No events for the selected filters.
Indications
Approved for
Studied for
Mechanism of action
- Glucan synthaseINHIBITOR
GSL2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- fuganlin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02622659 | Phase 4 | Mar 1, 2012 | Central South University, Changzhi City People's Hospital, Changzhou traditional Chinese medicine hospital, Chongqing Medical University, Guangxi Medical University, Guangzhou Yipinhong Pharmaceutical CO.,LTD, Handan Traditional Chinese Medicine Hospital, Luohe Hospital of Traditional Chinese Medicine, Nanchang University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (9)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Central South University | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Changzhi City People's Hospital | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Changzhou traditional Chinese medicine hospital | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Chongqing Medical University | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Guangxi Medical University | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Guangzhou Yipinhong Pharmaceutical CO.,LTD | For profit | 1 | 1 | 1 | 2012 |
| Handan Traditional Chinese Medicine Hospital | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Luohe Hospital of Traditional Chinese Medicine | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Nanchang University | Academic/Hospital | 1 | 0 | 1 | 2012 |
9 organizations
Page 1 / 1